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Concerning batch release in the pharmaceutical industry, the conformity analyses 
can be time consuming if all of them are performed after the manufacturing 
process. From this concept is born Process Analytical Technology (PAT) (1): it 
enables to monitor in real time each critical step of a manufacturing process 
reducing batch release time. Moreover, thanks to its real time character, PAT 
gives also the opportunity to tune manufacturing parameters in order to avoid the 
loss of potential batches. Pellets manufacturing process involves many steps such 
as blending, granulation, extrusion, spheronization and drying. A real time 
monitoring system like PAT is then particularly convenient to control such a 
complex process (2). Thanks to its non invasive, non destructive character and 
fast data acquisition, near infrared spectroscopy is more and more integrated in 
the PAT system, especially in the pharmaceutical field (2, 3). The aim of the 
present study was to develop and finally validate a near infrared model that was 
able to determine accurately a moisture content ranging from 1 to 8 % in 
pharmaceutical pellets  
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